Glycan encapsulated gold nanoparticles selectively inhibit Shiga toxins 1 and 2

Bioconjugate Chemistry

Volumn 21, Issue 8, 2010, Pages 1486-1493

  Kulkarni, Ashish A ^a   Fuller, Cynthia ^a   Korman, Henry ^a   Weiss, Alison A ^a   Iyer, Suri S ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLYCAN; GLYCOLIPID; GOLD NANOPARTICLE; VEROTOXIN 1; VEROTOXIN 2;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL SURFACE; COLUMN CHROMATOGRAPHY; DRUG BINDING SITE; DRUG INHIBITION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ENCAPSULATION; ESCHERICHIA COLI; KIDNEY CELL; LIPID RAFT; MONKEY; NONHUMAN; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; SHIGELLA DYSENTERIAE; THIN LAYER CHROMATOGRAPHY; TRANSMISSION ELECTRON MICROSCOPY; VERO CELL;

ESCHERICHIA COLI; SHIGELLA;

EID: 77955824449     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc100095w     Document Type: Article

References (52)

1. Siegler, R. L. (2003) Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome JAMA 290, 1379-81
2. Wong, C. S., Jelacic, S., Habeeb, R. L., Watkins, S. L., and Tarr, P. I. (2000) The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections N. Engl. J. Med. 342, 1930-6
3. Rutjes, N. W., Binnington, B. A., Smith, C. R., Maloney, M. D., and Lingwood, C. A. (2002) Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model Kidney Int. 62, 832-45
4. Sandvig, K. and van Deurs, B. (1996) Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin Physiol. Rev. 76, 949-66
5. Kitov, P. I., Sadowska, J. M., Mulvey, G., Armstrong, G. D., Ling, H., Pannu, N. S., Read, R. J., and Bundle, D. R. (2000) Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands Nature 403, 669-72
6. Neri, P., Nagano, S. I., Yokoyama, S., Dohi, H., Kobayashi, K., Miura, T., Inazu, T., Sugiyama, T., Nishida, Y., and Mori, H. (2007) Neutralizing activity of polyvalent Gb3, Gb2 and galacto-trehalose models against Shiga toxins Microbiol. Immunol. 51, 581-92
7. Dohi, H., Nishida, Y., Mizuno, M., Shinkai, M., Kobayashi, T., Takeda, T., Uzawa, H., and Kobayashi, K. (1999) Synthesis of an artificial glycoconjugate polymer carrying Pk-antigenic trisaccharide and its potent neutralization activity against Shiga-like toxin Bioorg. Med. Chem. 7, 2053-62
8. Kitov, P. I., Mulvey, G. L., Griener, T. P., Lipinski, T., Solomon, D., Paszkiewicz, E., Jacobson, J. M., Sadowska, J. M., Suzuki, M., Yamamura, K., Armstrong, G. D., and Bundle, D. R. (2008) In vivo supramolecular templating enhances the activity of multivalent ligands: a potential therapeutic against the Escherichia coli O157 AB5 toxins Proc. Natl. Acad. Sci. U.S.A. 105, 16837-42
9. Griener, T. P., Mulvey, G. L., Marcato, P., and Armstrong, G. D. (2007) Differential binding of Shiga toxin 2 to human and murine neutrophils J. Med. Microbiol. 56, 1423-30
10. Trachtman, H., Cnaan, A., Christen, E., Gibbs, K., Zhao, S., Acheson, D. W., Weiss, R., Kaskel, F. J., Spitzer, A., and Hirschman, G. H. (2003) Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial JAMA 290, 1337-44
11. Boerlin, P., McEwen, S. A., Boerlin-Petzold, F., Wilson, J. B., Johnson, R. P., and Gyles, C. L. (1999) Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans J. Clin. Microbiol. 37, 497-503
12. Siegler, R. L., Obrig, T. G., Pysher, T. J., Tesh, V. L., Denkers, N. D., and Taylor, F. B. (2003) Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome Pediatr. Nephrol. 18, 92-6
13. Armstrong, G. D., Mulvey, G. L., Marcato, P., Griener, T. P., Kahan, M. C., Tennent, G. A., Sabin, C. A., Chart, H., and Pepys, M. B. (2006) Human serum amyloid P component protects against Escherichia coli O157:H7 Shiga toxin 2 in vivo: therapeutic implications for hemolytic-uremic syndrome J. Infect. Dis. 193, 1120-4
14. Gamage, S. D., Patton, A. K., Strasser, J. E., Chalk, C. L., and Weiss, A. A. (2006) Commensal bacteria influence Escherichia coli O157:H7 persistence and Shiga toxin production in the mouse intestine Infect. Immunol. 74, 1977-83
15. Atkinson, R., Johnson, G., Root, T., Halse, T., Wroblewski, D., Davies, M., Byrd, A., Long, L., Demma, L., Angulo, F., Bopp, C., Gerner-Smidt, P., Strockbine, N., Greene, K., Swaminathan, B., Griffin, P., Schaffzin, J., and Goode, B. (2006) Morbidity and Mortality Weekly Report 1042-1045
16. Kale, R. R., McGannon, C. M., Fuller-Schaefer, C., Hatch, D. M., Flagler, M. J., Gamage, S. D., Weiss, A. A., and Iyer, S. S. (2008) Differentiation between structurally homologous Shiga 1 and Shiga 2 toxins by using synthetic glycoconjugates Angew. Chem., Int. Ed. Engl. 47, 1265-1268
17. Kale, R. R., McGannon, C. M., Fuller-Schaefer, C., Hatch, D. M., Flagler, M. J., Gamage, S. D., Weiss, A. A., and Iyer, S. S. (2008) Differentiation between structurally homologous Shiga 1 and Shiga 2 toxins by using synthetic glycoconjugates Angew. Chem., Int. Ed. Engl. 47, 1265-8
18. Mallidi, S., Larson, T., Tam, J., Joshi, P. P., Karpiouk, A., Sokolov, K., and Emelianov, S. (2009) Multiwavelength photoacoustic imaging and plasmon resonance coupling of gold nanoparticles for selective detection of cancer. Nano Lett.
19. Popovtzer, R., Agrawal, A., Kotov, N. A., Popovtzer, A., Balter, J., Carey, T. E., and Kopelman, R. (2008) Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett.
20. Zhang, J., Wang, J., Xu, X., Zhu, H., Wang, Z., Yang, F., Zhang, B., and Yang, X. (2009) A one-dimensional network from the self-assembly of gold nanoparticles by a necklace-like polyelectrolyte template mediated by metallic ion coordination Nanotechnology 20, 295603
21. Toster, J., Iyer, K. S., Burtovyy, R., Burgess, S. S., Luzinov, I. A., and Raston, C. L. (2009) Regiospecific assembly of gold nanoparticles around the pores of diatoms: toward three-dimensional nanoarrays J. Am. Chem. Soc. 131, 8356-7
22. Muthu, M. S. and Singh, S. (2009) Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders Nanomedicine 4, 105-18
23. Hwu, J. R., Lin, Y. S., Josephrajan, T., Hsu, M. H., Cheng, F. Y., Yeh, C. S., Su, W. C., and Shieh, D. B. (2009) Targeted Paclitaxel by conjugation to iron oxide and gold nanoparticles J. Am. Chem. Soc. 131, 66-8
24. Jain, J., Arora, S., Rajwade, J., Khandelwal, S., and Paknikar, K. M. (2009) Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Mol. Pharmaceut.
25. de La Fuente, J. M., Barrientos, A. G., Rojas, T. C., Rojo, J., Canada, J., Fernandez, A., and Penades, S. (2001) Gold glyconanoparticles as water-soluble polyvalent models to study carbohydrate interactions Angew. Chem., Int. Ed. Engl. 40, 2257-2261
26. de la Fuente, J. M. and Penades, S. (2006) Glyconanoparticles: types, synthesis and applications in glycoscience, biomedicine and material science Biochim. Biophys. Acta 1760, 636-51
27. Barrientos, A. G., de la Fuente, J. M., Rojas, T. C., Fernandez, A., and Penades, S. (2003) Gold glyconanoparticles: synthetic polyvalent ligands mimicking glycocalyx-like surfaces as tools for glycobiological studies Chemistry 9, 1909-21
28. Lin, C. C., Yeh, Y. C., Yang, C. Y., Chen, G. F., Chen, Y. C., Wu, Y. C., and Chen, C. C. (2003) Quantitative analysis of multivalent interactions of carbohydrate-encapsulated gold nanoparticles with concanavalin A Chem. Commun. (Camb.) 2920-1
29. Schofield, C. L., Field, R. A., and Russell, D. A. (2007) Glyconanoparticles for the colorimetric detection of cholera toxin Anal. Chem. 79, 1356-61
30. El-Boubbou, K., Gruden, C., and Huang, X. (2007) Magnetic glyco-nanoparticles: a unique tool for rapid pathogen detection, decontamination, and strain differentiation J. Am. Chem. Soc. 129, 13392-3
31. van Kasteren, S. I., Campbell, S. J., Serres, S., Anthony, D. C., Sibson, N. R., and Davis, B. G. (2009) Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease Proc. Natl. Acad. Sci. U.S.A. 106, 18-23
32. Rojo, J., Diaz, V., de la Fuente, J. M., Segura, I., Barrientos, A. G., Riese, H. H., Bernad, A., and Penades, S. (2004) Gold glyconanoparticles as new tools in antiadhesive therapy ChemBioChem 5, 291-7
33. Reynolds, A. J., Haines, A. H., and Russell, D. A. (2006) Gold glyconanoparticles for mimics and measurement of metal ion-mediated carbohydrate-carbohydrate interactions Langmuir 22, 1156-63
34. de la Fuente, J. M. and Penades, S. (2004) Understanding carbohydrate-carbohydrate interactions by means of glyconanotechnology Glycoconj. J. 21, 149-63
35. de la Fuente, J. M., Eaton, P., Barrientos, A. G., Menendez, M., and Penades, S. (2005) Thermodynamic evidence for Ca2+-mediated self-aggregation of Lewis X gold glyconanoparticles. A model for cell adhesion via carbohydrate-carbohydrate interaction J. Am. Chem. Soc. 127, 6192-7
36. Bowman, M. C., Ballard, T. E., Ackerson, C. J., Feldheim, D. L., Margolis, D. M., and Melander, C. (2008) Inhibition of HIV fusion with multivalent gold nanoparticles J. Am. Chem. Soc. 130, 6896-7
37. Martinez-Avila, O., Bedoya, L. M., Marradi, M., Clavel, C., Alcami, J., and Penades, S. (2009) Multivalent manno-glyconanoparticles inhibit DC-SIGN-mediated HIV-1 trans-infection of human T cells ChemBioChem 10, 1806-9
38. Rogers, J. V., Parkinson, C. V., Choi, Y. W., Speshock, J. L., and Hussain, S. M. (2008) A preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque formation Nanoscale Res. Lett. 3, 129-133
39. Lu, L., Sun, R. W. Y., Chen, R., Hui, C. K., Ho, C. M., Luk, J. M., Lau, G. K. K., and Che, C. M. (2008) Silver nanoparticles inhibit hepatitis B virus replication Antiviral Ther. 13, 253-262
40. M. Brust, J. F., Bethell, D., Schiffrin, D. J., and Kiely, C. (1995) Synthesis and reactions of functionalised gold nanoparticles J. Chem. Soc.: Chem. Commun. 1655-1656
41. Chien, Y. Y., Jan, M. D., Adak, A. K., Tzeng, H. C., Lin, Y. P., Chen, Y. J., Wang, K. T., Chen, C. T., Chen, C. C., and Lin, C. C. (2008) Globotriose-functionalized gold nanoparticles as multivalent probes for Shiga-like toxin ChemBioChem 9, 1100-9
42. Pear, W. S., Miller, J. P., Xu, L., Pui, J. C., Soffer, B., Quackenbush, R. C., Pendergast, A. M., Bronson, R., Aster, J. C., Scott, M. L., and Baltimore, D. (1998) Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow Blood 92, 3780-92
43. Sherrill, J. D. and Miller, W. E. (2006) G protein-coupled receptor (GPCR) kinase 2 regulates agonist-independent Gq/11 signaling from the mouse cytomegalovirus GPCR M33 J. Biol. Chem. 281, 39796-805
44. McGannon, C. M., Fuller, C., and Weiss, A. A. (2010) Different classes of antibiotics differentially influence Shiga toxin production Antimicrob. Agents Chemother. (in press) doi: 10. 1128/AAC.01783-09.
45. Hill, H. D., Millstone, J. E., Banholzer, M. J., and Mirkin, C. A. (2009) The role radius of curvature plays in thiolated oligonucleotide loading on gold nanoparticles ACS Nano 3, 418-24
46. Chandrasekaran, A., Srinivasan, A., Raman, R., Viswanathan, K., Raguram, S., Tumpey, T. M., Sasisekharan, V., and Sasisekharan, R. (2008) Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin Nat. Biotechnol. 26, 107-13
47. Lewallen, D. M., Siler, D., and Iyer, S. S. (2009) Factors affecting protein-glycan specificity: effect of spacers and incubation time ChemBioChem 10, 1486-1489
48. Kokai-Kun, J. F., Melton-Celsa, A. R., and OBrien, A. D. (2000) Elastase in intestinal mucus enhances the cytotoxicity of Shiga toxin type 2d J. Biol. Chem. 275, 3713-21
49. Dhayal, M. and Ratner, D. M. (2009) XPS and SPR analysis of glycoarray surface density Langmuir 25, 2181-7
50. Lewallen, D. M., Siler, D., and Iyer, S. S. (2009) Factors affecting protein-glycan specificity: effect of spacers and incubation time ChemBioChem 10, 1486-9
51. Kitov, P. I., Shimizu, H., Homans, S. W., and Bundle, D. R. (2003) Optimization of tether length in nonglycosidically linked bivalent ligands that target sites 2 and 1 of a Shiga-like toxin J. Am. Chem. Soc. 125, 3284-94
52. Fraser, M. E., Fujinaga, M., Cherney, M. M., Melton-Celsa, A. R., Twiddy, E. M., OBrien, A. D., and James, M. N. (2004) Structure of shiga toxin type 2 (Stx2) from Escherichia coli O157:H7 J. Biol. Chem. 279, 27511-7